These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17987523)

  • 41. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
    Liu F; Grauer S; Kelley C; Navarra R; Graf R; Zhang G; Atkinson PJ; Popiolek M; Wantuch C; Khawaja X; Smith D; Olsen M; Kouranova E; Lai M; Pruthi F; Pulicicchio C; Day M; Gilbert A; Pausch MH; Brandon NJ; Beyer CE; Comery TA; Logue S; Rosenzweig-Lipson S; Marquis KL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):827-39. PubMed ID: 18753411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances in positive allosteric modulators of the AMPA receptor.
    Morrow JA; Maclean JK; Jamieson C
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):571-9. PubMed ID: 17002217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allosteric approaches to the targeting of G-protein-coupled receptors for novel drug discovery: a critical assessment.
    Raddatz R; Schaffhauser H; Marino MJ
    Biochem Pharmacol; 2007 Aug; 74(3):383-91. PubMed ID: 17572390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5).
    Williams DL; Lindsley CW
    Curr Top Med Chem; 2005; 5(9):825-46. PubMed ID: 16178729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-activity relationships for negative allosteric mGluR5 modulators.
    Kaae BH; Harpsøe K; Kvist T; Mathiesen JM; Mølck C; Gloriam D; Jimenez HN; Uberti MA; Nielsen SM; Nielsen B; Bräuner-Osborne H; Sauerberg P; Clausen RP; Madsen U
    ChemMedChem; 2012 Mar; 7(3):440-51. PubMed ID: 22267204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
    Bridges TM; Lindsley CW
    ACS Chem Biol; 2008 Sep; 3(9):530-41. PubMed ID: 18652471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel heterocyclic compounds as mGlu5 antagonists: WO2009015897.
    Doller D; Li G; Brodbeck RM; Thomsen C
    Expert Opin Ther Pat; 2010 Mar; 20(3):435-9. PubMed ID: 20180623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationship of thiopyrimidines as mGluR5 antagonists.
    Hammerland LG; Johansson M; Malmström J; Mattsson JP; Minidis AB; Nilsson K; Peterson A; Wensbo D; Wållberg A; Osterlund K
    Bioorg Med Chem Lett; 2006 May; 16(9):2467-9. PubMed ID: 16481165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators.
    Pinkerton AB; Cube RV; Hutchinson JH; James JK; Gardner MF; Rowe BA; Schaffhauser H; Rodriguez DE; Campbell UC; Daggett LP; Vernier JM
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1565-71. PubMed ID: 15745798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allosteric modulation of G protein-coupled receptors.
    Soudijn W; van Wijngaarden I; IJzerman AP
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):749-55. PubMed ID: 12630295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 - present).
    Celanire S; Sebhat I; Wichmann J; Mayer S; Schann S; Gatti S
    Expert Opin Ther Pat; 2015 Jan; 25(1):69-90. PubMed ID: 25435285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in positive allosteric modulators of metabotropic glutamate receptors.
    Shipe WD; Wolkenberg SE; Williams DL; Lindsley CW
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):449-57. PubMed ID: 16022181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5.
    Burdi DF; Hunt R; Fan L; Hu T; Wang J; Guo Z; Huang Z; Wu C; Hardy L; Detheux M; Orsini MA; Quinton MS; Lew R; Spear K
    J Med Chem; 2010 Oct; 53(19):7107-18. PubMed ID: 20809633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of novel positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
    Varnes JG; Marcus AP; Mauger RC; Throner SR; Hoesch V; King MM; Wang X; Sygowski LA; Spear N; Gadient R; Brown DG; Campbell JB
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1402-6. PubMed ID: 21295468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structures of mGluRs shed light on the challenges of drug development of allosteric modulators.
    Bennett KA; Doré AS; Christopher JA; Weiss DR; Marshall FH
    Curr Opin Pharmacol; 2015 Feb; 20():1-7. PubMed ID: 25462286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor.
    Pinkerton AB; Vernier JM; Schaffhauser H; Rowe BA; Campbell UC; Rodriguez DE; Lorrain DS; Baccei CS; Daggett LP; Bristow LJ
    J Med Chem; 2004 Aug; 47(18):4595-9. PubMed ID: 15317469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.
    Uslaner JM; Parmentier-Batteur S; Flick RB; Surles NO; Lam JS; McNaughton CH; Jacobson MA; Hutson PH
    Neuropharmacology; 2009; 57(5-6):531-8. PubMed ID: 19627999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The identification of novel orally active mGluR5 antagonist GSK2210875.
    Pilla M; Andreoli M; Tessari M; Delle-Fratte S; Roth A; Butler S; Brown F; Shah P; Bettini E; Cavallini P; Benedetti R; Minick D; Smith P; Tehan B; D'Alessandro P; Lorthioir O; Ball C; Garzya V; Goodacre C; Watson S
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7521-4. PubMed ID: 21051228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators.
    Orgován Z; Ferenczy GG; Keserű GM
    Curr Top Med Chem; 2019; 19(19):1768-1781. PubMed ID: 31393248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allosteric modulation of metabotropic glutamate receptors.
    Sheffler DJ; Gregory KJ; Rook JM; Conn PJ
    Adv Pharmacol; 2011; 62():37-77. PubMed ID: 21907906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.